PlainRecalls
FDA Drug Low Class III Terminated

Minocycline Hydrochloride Extended-Release Tablets, USP, 105 mg*, 30-count bottle, Rx Only, Manufactured by: Alkem Laboratories Ltd., Mumbai - 400 013 India, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054, NDC 67877-438-30.

Reported: February 12, 2020 Initiated: January 22, 2020 #D-0827-2020

Product Description

Minocycline Hydrochloride Extended-Release Tablets, USP, 105 mg*, 30-count bottle, Rx Only, Manufactured by: Alkem Laboratories Ltd., Mumbai - 400 013 India, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054, NDC 67877-438-30.

Reason for Recall

Failed Dissolution Specifications: low out of specification results for dissolution testing.

Details

Recalling Firm
Ascend Laboratories LLC
Units Affected
4728 bottles
Distribution
Nationwide in the USA
Location
Parsippany, NJ

Frequently Asked Questions

What product was recalled?
Minocycline Hydrochloride Extended-Release Tablets, USP, 105 mg*, 30-count bottle, Rx Only, Manufactured by: Alkem Laboratories Ltd., Mumbai - 400 013 India, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054, NDC 67877-438-30.. Recalled by Ascend Laboratories LLC. Units affected: 4728 bottles.
Why was this product recalled?
Failed Dissolution Specifications: low out of specification results for dissolution testing.
Which agency issued this recall?
This recall was issued by the FDA Drug on February 12, 2020. Severity: Low. Recall number: D-0827-2020.